PubRank

Carlo M Croce

Author PubWeight™ 1005.07‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 MicroRNA signatures in human cancers. Nat Rev Cancer 2006 46.29
2 A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A 2006 40.09
3 Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A 2002 32.26
4 Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci U S A 2004 28.29
5 MicroRNA gene expression deregulation in human breast cancer. Cancer Res 2005 27.56
6 A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N Engl J Med 2005 26.02
7 Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 2006 23.59
8 miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci U S A 2005 21.51
9 MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias. Proc Natl Acad Sci U S A 2004 14.59
10 An oligonucleotide microchip for genome-wide microRNA profiling in human and mouse tissues. Proc Natl Acad Sci U S A 2004 13.66
11 MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA 2008 12.26
12 MicroRNA-133 controls cardiac hypertrophy. Nat Med 2007 11.68
13 Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in E(mu)-miR155 transgenic mice. Proc Natl Acad Sci U S A 2006 10.65
14 MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis. JAMA 2007 9.97
15 MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B. Proc Natl Acad Sci U S A 2007 9.82
16 MicroRNA signatures in human ovarian cancer. Cancer Res 2007 9.45
17 MicroRNAs in Cancer. Annu Rev Med 2009 9.37
18 Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures. Cell Stem Cell 2009 8.62
19 The role of microRNA genes in papillary thyroid carcinoma. Proc Natl Acad Sci U S A 2005 8.60
20 E2F1-regulated microRNAs impair TGFbeta-dependent cell-cycle arrest and apoptosis in gastric cancer. Cancer Cell 2008 7.56
21 A microRNA signature of hypoxia. Mol Cell Biol 2006 7.24
22 A microRNA DNA methylation signature for human cancer metastasis. Proc Natl Acad Sci U S A 2008 7.14
23 Interferon modulation of cellular microRNAs as an antiviral mechanism. Nature 2007 7.04
24 MicroRNA expression and function in cancer. Trends Mol Med 2006 7.02
25 ALL-1 is a histone methyltransferase that assembles a supercomplex of proteins involved in transcriptional regulation. Mol Cell 2002 6.72
26 MicroRNA expression, survival, and response to interferon in liver cancer. N Engl J Med 2009 6.13
27 Targeting microRNAs in cancer: rationale, strategies and challenges. Nat Rev Drug Discov 2010 6.07
28 MicroRNAs in cancer: small molecules with a huge impact. J Clin Oncol 2009 5.92
29 MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1. Blood 2009 5.87
30 Knockdown of ALR (MLL2) reveals ALR target genes and leads to alterations in cell adhesion and growth. Mol Cell Biol 2006 5.74
31 Tcl1 expression in chronic lymphocytic leukemia is regulated by miR-29 and miR-181. Cancer Res 2006 5.72
32 Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis. Lancet Oncol 2009 5.56
33 MicroRNAs 221 and 222 inhibit normal erythropoiesis and erythroleukemic cell growth via kit receptor down-modulation. Proc Natl Acad Sci U S A 2005 5.54
34 Global and Hox-specific roles for the MLL1 methyltransferase. Proc Natl Acad Sci U S A 2005 5.53
35 MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review. EMBO Mol Med 2012 5.46
36 Ultraconserved regions encoding ncRNAs are altered in human leukemias and carcinomas. Cancer Cell 2007 5.40
37 MicroRNA expression abnormalities in pancreatic endocrine and acinar tumors are associated with distinctive pathologic features and clinical behavior. J Clin Oncol 2006 5.40
38 Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. Cancer Res 2007 5.40
39 MicroRNA signatures associated with cytogenetics and prognosis in acute myeloid leukemia. Blood 2008 5.23
40 Crystal structures of Tcl1 family oncoproteins and their conserved surface features. ScientificWorldJournal 2002 5.20
41 Genomic profiling of microRNA and messenger RNA reveals deregulated microRNA expression in prostate cancer. Cancer Res 2008 5.16
42 MicroRNAs bind to Toll-like receptors to induce prometastatic inflammatory response. Proc Natl Acad Sci U S A 2012 5.07
43 MicroRNA expression in cytogenetically normal acute myeloid leukemia. N Engl J Med 2008 4.91
44 Human chronic lymphocytic leukemia modeled in mouse by targeted TCL1 expression. Proc Natl Acad Sci U S A 2002 4.86
45 Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer. Proc Natl Acad Sci U S A 2008 4.79
46 NF-kappaB-YY1-miR-29 regulatory circuitry in skeletal myogenesis and rhabdomyosarcoma. Cancer Cell 2008 4.57
47 Identification of metastasis-related microRNAs in hepatocellular carcinoma. Hepatology 2008 4.50
48 Micro-RNA profiling in kidney and bladder cancers. Urol Oncol 2007 4.35
49 MiR-15a and miR-16-1 cluster functions in human leukemia. Proc Natl Acad Sci U S A 2008 4.33
50 Distinctive microRNA signature of acute myeloid leukemia bearing cytoplasmic mutated nucleophosmin. Proc Natl Acad Sci U S A 2008 4.26
51 miR-221 overexpression contributes to liver tumorigenesis. Proc Natl Acad Sci U S A 2009 4.15
52 MicroRNA signatures in tissues and plasma predict development and prognosis of computed tomography detected lung cancer. Proc Natl Acad Sci U S A 2011 4.11
53 The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform. Gynecol Oncol 2008 4.10
54 miR-328 functions as an RNA decoy to modulate hnRNP E2 regulation of mRNA translation in leukemic blasts. Cell 2010 4.07
55 CD34+ hematopoietic stem-progenitor cell microRNA expression and function: a circuit diagram of differentiation control. Proc Natl Acad Sci U S A 2007 4.06
56 MicroRNAs 17-5p-20a-106a control monocytopoiesis through AML1 targeting and M-CSF receptor upregulation. Nat Cell Biol 2007 4.02
57 Genetic and epigenetic silencing of microRNA-203 enhances ABL1 and BCR-ABL1 oncogene expression. Cancer Cell 2008 4.01
58 Identification of microRNA-181 by genome-wide screening as a critical player in EpCAM-positive hepatic cancer stem cells. Hepatology 2009 3.92
59 Clinical response and miR-29b predictive significance in older AML patients treated with a 10-day schedule of decitabine. Proc Natl Acad Sci U S A 2010 3.86
60 MicroRNA fingerprints during human megakaryocytopoiesis. Proc Natl Acad Sci U S A 2006 3.80
61 MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis. Proc Natl Acad Sci U S A 2008 3.77
62 MiR-21 is an EGFR-regulated anti-apoptotic factor in lung cancer in never-smokers. Proc Natl Acad Sci U S A 2009 3.64
63 Biological functions of miR-29b contribute to positive regulation of osteoblast differentiation. J Biol Chem 2009 3.62
64 Downregulation of p53-inducible microRNAs 192, 194, and 215 impairs the p53/MDM2 autoregulatory loop in multiple myeloma development. Cancer Cell 2010 3.52
65 MicroRNAs in cancer. Annu Rev Pathol 2013 3.50
66 MiRNAs and cancer. Am J Pathol 2009 3.42
67 Familial cancer associated with a polymorphism in ARLTS1. N Engl J Med 2005 3.35
68 MicroRNA expression profiling of human metastatic cancers identifies cancer gene targets. J Pathol 2009 3.29
69 A microRNA signature for a BMP2-induced osteoblast lineage commitment program. Proc Natl Acad Sci U S A 2008 3.29
70 MicroRNA 29b functions in acute myeloid leukemia. Blood 2009 3.19
71 Akt induces enhanced myocardial contractility and cell size in vivo in transgenic mice. Proc Natl Acad Sci U S A 2002 3.18
72 Methylation mediated silencing of MicroRNA-1 gene and its role in hepatocellular carcinogenesis. Cancer Res 2008 3.16
73 Association of a microRNA/TP53 feedback circuitry with pathogenesis and outcome of B-cell chronic lymphocytic leukemia. JAMA 2011 3.16
74 MicroRNAs modulate the chemosensitivity of tumor cells. Mol Cancer Ther 2008 3.06
75 MicroRNA expression in squamous cell carcinoma and adenocarcinoma of the esophagus: associations with survival. Clin Cancer Res 2009 3.03
76 The miR-17/92 polycistron is up-regulated in sonic hedgehog-driven medulloblastomas and induced by N-myc in sonic hedgehog-treated cerebellar neural precursors. Cancer Res 2009 3.03
77 Emerging role of miR-106b-25/miR-17-92 clusters in the control of transforming growth factor beta signaling. Cancer Res 2008 3.01
78 microRNA involvement in human cancer. Carcinogenesis 2012 2.98
79 MicroRNAs 221 and 222 bypass quiescence and compromise cell survival. Cancer Res 2008 2.97
80 Pancreatic endocrine tumors: expression profiling evidences a role for AKT-mTOR pathway. J Clin Oncol 2009 2.94
81 p53 regulates epithelial-mesenchymal transition through microRNAs targeting ZEB1 and ZEB2. J Exp Med 2011 2.93
82 Stem cell-like micro-RNA signature driven by Myc in aggressive liver cancer. Proc Natl Acad Sci U S A 2010 2.91
83 Single-nucleotide polymorphisms inside microRNA target sites influence tumor susceptibility. Cancer Res 2010 2.82
84 Reprogramming of miRNA networks in cancer and leukemia. Genome Res 2010 2.65
85 Preclinical activity of a novel CRM1 inhibitor in acute myeloid leukemia. Blood 2012 2.65
86 miR-155: on the crosstalk between inflammation and cancer. Int Rev Immunol 2009 2.64
87 Mammalian microRNAs: a small world for fine-tuning gene expression. Mamm Genome 2006 2.64
88 Stromal control of cystine metabolism promotes cancer cell survival in chronic lymphocytic leukaemia. Nat Cell Biol 2012 2.59
89 Downregulation of microRNA expression in the lungs of rats exposed to cigarette smoke. FASEB J 2008 2.58
90 microRNA-205 regulates HER3 in human breast cancer. Cancer Res 2009 2.53
91 MicroRNA expression profiles for the NCI-60 cancer cell panel. Mol Cancer Ther 2007 2.53
92 Concern Parkin, a gene implicated in autosomal recessive juvenile parkinsonism, is a candidate tumor suppressor gene on chromosome 6q25-q27. Proc Natl Acad Sci U S A 2003 2.52
93 miRNA signatures associate with pathogenesis and progression of osteosarcoma. Cancer Res 2012 2.52
94 EGFR and MET receptor tyrosine kinase-altered microRNA expression induces tumorigenesis and gefitinib resistance in lung cancers. Nat Med 2011 2.46
95 MicroRNA expression profiling using microarrays. Nat Protoc 2008 2.44
96 Aberrant chromatin at genes encoding stem cell regulators in human mixed-lineage leukemia. Genes Dev 2008 2.41
97 mRNA/microRNA gene expression profile in microsatellite unstable colorectal cancer. Mol Cancer 2007 2.40
98 MicroRNA-29a regulates intestinal membrane permeability in patients with irritable bowel syndrome. Gut 2009 2.39
99 Targeted deletion of Wwox reveals a tumor suppressor function. Proc Natl Acad Sci U S A 2007 2.37
100 Sp1/NFkappaB/HDAC/miR-29b regulatory network in KIT-driven myeloid leukemia. Cancer Cell 2010 2.37
101 MicroRNA microarray identifies Let-7i as a novel biomarker and therapeutic target in human epithelial ovarian cancer. Cancer Res 2008 2.35
102 Mechanisms of microRNA deregulation in human cancer. Cell Cycle 2008 2.30
103 Oncogenic role of miR-483-3p at the IGF2/483 locus. Cancer Res 2010 2.30
104 A network connecting Runx2, SATB2, and the miR-23a~27a~24-2 cluster regulates the osteoblast differentiation program. Proc Natl Acad Sci U S A 2010 2.29
105 MicroRNAs. Cancer J 2008 2.28
106 In hepatocellular carcinoma miR-519d is up-regulated by p53 and DNA hypomethylation and targets CDKN1A/p21, PTEN, AKT3 and TIMP2. J Pathol 2012 2.27
107 MicroRNAs in normal and malignant hematopoiesis. Curr Opin Hematol 2008 2.23
108 Small molecule enoxacin is a cancer-specific growth inhibitor that acts by enhancing TAR RNA-binding protein 2-mediated microRNA processing. Proc Natl Acad Sci U S A 2011 2.21
109 MicroRNAs in the pathogenesis of cancer. Semin Oncol 2011 2.15
110 SnapShot: MicroRNAs in Cancer. Cell 2009 2.10
111 17-DMAG targets the nuclear factor-kappaB family of proteins to induce apoptosis in chronic lymphocytic leukemia: clinical implications of HSP90 inhibition. Blood 2010 2.07
112 Breast cancer signatures for invasiveness and prognosis defined by deep sequencing of microRNA. Proc Natl Acad Sci U S A 2012 2.07
113 A program of microRNAs controls osteogenic lineage progression by targeting transcription factor Runx2. Proc Natl Acad Sci U S A 2011 2.05
114 Modulation of mismatch repair and genomic stability by miR-155. Proc Natl Acad Sci U S A 2010 2.05
115 microRNAs: Master regulators as potential therapeutics in cancer. Annu Rev Pharmacol Toxicol 2011 2.02
116 The E3 ubiquitin ligase Itch controls the protein stability of p63. Proc Natl Acad Sci U S A 2006 2.01
117 MicroRNAs in human cancer: from research to therapy. J Cell Sci 2007 2.00
118 MicroRNA involvement in hepatocellular carcinoma. J Cell Mol Med 2008 1.99
119 MicroRNA-21 induces resistance to 5-fluorouracil by down-regulating human DNA MutS homolog 2 (hMSH2). Proc Natl Acad Sci U S A 2010 1.99
120 miRNA profiling of cancer. Curr Opin Genet Dev 2013 1.99
121 Overexpression of the HMGA2 gene in transgenic mice leads to the onset of pituitary adenomas. Oncogene 2002 1.99
122 Mutator activity induced by microRNA-155 (miR-155) links inflammation and cancer. Proc Natl Acad Sci U S A 2011 1.96
123 Chronic lymphocytic leukemia modeled in mouse by targeted miR-29 expression. Proc Natl Acad Sci U S A 2010 1.94
124 MicroRNA cluster 221-222 and estrogen receptor alpha interactions in breast cancer. J Natl Cancer Inst 2010 1.94
125 Characterization of the TCL-1 transgenic mouse as a preclinical drug development tool for human chronic lymphocytic leukemia. Blood 2006 1.92
126 WW domain-containing proteins, WWOX and YAP, compete for interaction with ErbB-4 and modulate its transcriptional function. Cancer Res 2005 1.91
127 Functional association between Wwox tumor suppressor protein and p73, a p53 homolog. Proc Natl Acad Sci U S A 2004 1.91
128 MicroRNA genes are frequently located near mouse cancer susceptibility loci. Proc Natl Acad Sci U S A 2007 1.90
129 Roles of small RNAs in tumor formation. Trends Mol Med 2010 1.89
130 NOTCH1 mutations in CLL associated with trisomy 12. Blood 2011 1.88
131 Expression and functional role of a transcribed noncoding RNA with an ultraconserved element in hepatocellular carcinoma. Proc Natl Acad Sci U S A 2010 1.87
132 Epstein-Barr virus-induced miR-155 attenuates NF-kappaB signaling and stabilizes latent virus persistence. J Virol 2008 1.86
133 Expression of microRNAs and protein-coding genes associated with perineural invasion in prostate cancer. Prostate 2008 1.86
134 A methodology for the combined in situ analyses of the precursor and mature forms of microRNAs and correlation with their putative targets. Nat Protoc 2009 1.85
135 Concern WWOX gene restoration prevents lung cancer growth in vitro and in vivo. Proc Natl Acad Sci U S A 2005 1.84
136 MiR-34a/c-Dependent PDGFR-α/β Downregulation Inhibits Tumorigenesis and Enhances TRAIL-Induced Apoptosis in Lung Cancer. PLoS One 2013 1.82
137 Epigenetically deregulated microRNA-375 is involved in a positive feedback loop with estrogen receptor alpha in breast cancer cells. Cancer Res 2010 1.82
138 13q14 deletions in CLL involve cooperating tumor suppressors. Blood 2010 1.79
139 Physical and functional interactions between the Wwox tumor suppressor protein and the AP-2gamma transcription factor. Cancer Res 2004 1.74
140 Chromosomal rearrangements and microRNAs: a new cancer link with clinical implications. J Clin Invest 2007 1.72
141 PP2A-activating drugs selectively eradicate TKI-resistant chronic myeloid leukemic stem cells. J Clin Invest 2013 1.72
142 Alterations of the tumor suppressor gene ARLTS1 in ovarian cancer. Cancer Res 2006 1.71
143 Karyotype-specific microRNA signature in chronic lymphocytic leukemia. Blood 2009 1.70
144 Association of inflammation-related and microRNA gene expression with cancer-specific mortality of colon adenocarcinoma. Clin Cancer Res 2009 1.67
145 The WWOX tumor suppressor is essential for postnatal survival and normal bone metabolism. J Biol Chem 2008 1.67
146 WWOX in biological control and tumorigenesis. J Cell Physiol 2007 1.66
147 MicroRNAs as therapeutic targets in cancer. Transl Res 2011 1.64
148 Lack of the architectural factor HMGA1 causes insulin resistance and diabetes in humans and mice. Nat Med 2005 1.64
149 Genetic alterations of the tumor suppressor gene WWOX in esophageal squamous cell carcinoma. Cancer Res 2002 1.62
150 Tcl1 functions as a transcriptional regulator and is directly involved in the pathogenesis of CLL. Proc Natl Acad Sci U S A 2008 1.62
151 Akt phosphorylates and regulates Pdcd4 tumor suppressor protein. Cancer Res 2005 1.61
152 E(mu)-TCL1 mice represent a model for immunotherapeutic reversal of chronic lymphocytic leukemia-induced T-cell dysfunction. Proc Natl Acad Sci U S A 2009 1.61
153 At least ten genes define the imprinted Dlk1-Dio3 cluster on mouse chromosome 12qF1. PLoS One 2009 1.60
154 MicroRNAs play a central role in molecular dysfunctions linking inflammation with cancer. Immunol Rev 2013 1.60
155 The down-regulation of miR-125b in chronic lymphocytic leukemias leads to metabolic adaptation of cells to a transformed state. Blood 2012 1.60
156 MicroRNAs, the immune system and rheumatic disease. Nat Clin Pract Rheumatol 2008 1.55
157 Loss of WWOX expression in gastric carcinoma. Clin Cancer Res 2004 1.55
158 B cell receptors in TCL1 transgenic mice resemble those of aggressive, treatment-resistant human chronic lymphocytic leukemia. Proc Natl Acad Sci U S A 2006 1.55
159 Prognostic microRNA/mRNA signature from the integrated analysis of patients with invasive breast cancer. Proc Natl Acad Sci U S A 2013 1.54
160 Transgenic mice overexpressing the wild-type form of the HMGA1 gene develop mixed growth hormone/prolactin cell pituitary adenomas and natural killer cell lymphomas. Oncogene 2005 1.53
161 Resveratrol decreases the levels of miR-155 by upregulating miR-663, a microRNA targeting JunB and JunD. Carcinogenesis 2010 1.52
162 MiR-494 is regulated by ERK1/2 and modulates TRAIL-induced apoptosis in non-small-cell lung cancer through BIM down-regulation. Proc Natl Acad Sci U S A 2012 1.52
163 miR-221 silencing blocks hepatocellular carcinoma and promotes survival. Cancer Res 2011 1.51
164 Causes and consequences of microRNA dysregulation. Cancer J 2012 1.51
165 miR-155 regulates IFN-γ production in natural killer cells. Blood 2012 1.47
166 Is miR-29 an oncogene or tumor suppressor in CLL? Oncotarget 2010 1.46
167 A role for the WWOX gene in prostate cancer. Cancer Res 2006 1.45
168 The tumor suppressor gene WWOX at FRA16D is involved in pancreatic carcinogenesis. Clin Cancer Res 2004 1.45
169 A microRNA signature defines chemoresistance in ovarian cancer through modulation of angiogenesis. Proc Natl Acad Sci U S A 2013 1.44
170 miR-181b is a biomarker of disease progression in chronic lymphocytic leukemia. Blood 2011 1.44
171 Integrated microRNA and mRNA signatures associated with survival in triple negative breast cancer. PLoS One 2013 1.43
172 MicroRNA profiling as a tool to understand prognosis, therapy response and resistance in breast cancer. Eur J Cancer 2008 1.42
173 WW domain containing oxidoreductase gene expression is altered in non-small cell lung cancer. Cancer Res 2003 1.42
174 Interplay between microRNAs and the epigenetic machinery: an intricate network. Biochim Biophys Acta 2010 1.41
175 miR-218 directs a Wnt signaling circuit to promote differentiation of osteoblasts and osteomimicry of metastatic cancer cells. J Biol Chem 2012 1.39
176 Long-range interaction and correlation between MYC enhancer and oncogenic long noncoding RNA CARLo-5. Proc Natl Acad Sci U S A 2014 1.39
177 MicroRNA-1 is a candidate tumor suppressor and prognostic marker in human prostate cancer. Nucleic Acids Res 2011 1.39
178 Isoform-specific monoubiquitination, endocytosis, and degradation of alternatively spliced ErbB4 isoforms. Proc Natl Acad Sci U S A 2008 1.39
179 Epigenetic changes during disease progression in a murine model of human chronic lymphocytic leukemia. Proc Natl Acad Sci U S A 2009 1.39
180 Identification of differentially expressed microRNAs by microarray: a possible role for microRNA genes in pituitary adenomas. J Cell Physiol 2007 1.37
181 Association of Wwox with ErbB4 in breast cancer. Cancer Res 2007 1.37
182 Altered Runx1 subnuclear targeting enhances myeloid cell proliferation and blocks differentiation by activating a miR-24/MKP-7/MAPK network. Cancer Res 2009 1.37
183 miR-29ab1 deficiency identifies a negative feedback loop controlling Th1 bias that is dysregulated in multiple sclerosis. J Immunol 2012 1.35
184 Regulation of acute graft-versus-host disease by microRNA-155. Blood 2012 1.35
185 Allele loss and promoter hypermethylation of VHL, RAR-beta, RASSF1A, and FHIT tumor suppressor genes on chromosome 3p in esophageal squamous cell carcinoma. Cancer Res 2003 1.34
186 Haploinsufficiency of the Hmga1 gene causes cardiac hypertrophy and myelo-lymphoproliferative disorders in mice. Cancer Res 2006 1.34
187 The role of microRNA and other non-coding RNA in the pathogenesis of chronic lymphocytic leukemia. Best Pract Res Clin Haematol 2007 1.34
188 Retracted Unique microRNA profile in end-stage heart failure indicates alterations in specific cardiovascular signaling networks. J Biol Chem 2009 1.33
189 Chronic lymphocytic leukemia of Emu-TCL1 transgenic mice undergoes rapid cell turnover that can be offset by extrinsic CD257 to accelerate disease progression. Blood 2009 1.32
190 Expression of FRA16D/WWOX and FRA3B/FHIT genes in hematopoietic malignancies. Mol Cancer Res 2003 1.32
191 Insulin growth factor signaling is regulated by microRNA-486, an underexpressed microRNA in lung cancer. Proc Natl Acad Sci U S A 2013 1.32
192 Relationships of microRNA expression in mouse lung with age and exposure to cigarette smoke and light. FASEB J 2009 1.31
193 Comprehensive miRNA profiling of surgically staged endometrial cancer. Am J Obstet Gynecol 2010 1.30
194 Aberrant regulation of pVHL levels by microRNA promotes the HIF/VEGF axis in CLL B cells. Blood 2009 1.29
195 Resveratrol modulates the levels of microRNAs targeting genes encoding tumor-suppressors and effectors of TGFβ signaling pathway in SW480 cells. Biochem Pharmacol 2010 1.28
196 microRNA expression profiling identifies a four microRNA signature as a novel diagnostic and prognostic biomarker in triple negative breast cancers. Oncotarget 2014 1.28
197 Oncogenic All1 fusion proteins target Drosha-mediated microRNA processing. Proc Natl Acad Sci U S A 2007 1.27
198 Restoration of fragile histidine triad (FHIT) expression induces apoptosis and suppresses tumorigenicity in lung and cervical cancer cell lines. Proc Natl Acad Sci U S A 2002 1.27
199 Molecular basis of CLL. Semin Cancer Biol 2010 1.26
200 Disrupted microRNA expression caused by Mecp2 loss in a mouse model of Rett syndrome. Epigenetics 2010 1.26
201 Effect of rapamycin on mouse chronic lymphocytic leukemia and the development of nonhematopoietic malignancies in Emu-TCL1 transgenic mice. Cancer Res 2006 1.26
202 Cross-talk between MET and EGFR in non-small cell lung cancer involves miR-27a and Sprouty2. Proc Natl Acad Sci U S A 2013 1.24
203 Estrogen mediated-activation of miR-191/425 cluster modulates tumorigenicity of breast cancer cells depending on estrogen receptor status. PLoS Genet 2013 1.24
204 Microvesicles containing miRNAs promote muscle cell death in cancer cachexia via TLR7. Proc Natl Acad Sci U S A 2014 1.24
205 Liver tumorigenicity promoted by microRNA-221 in a mouse transgenic model. Hepatology 2012 1.23
206 Non-codingRNA sequence variations in human chronic lymphocytic leukemia and colorectal cancer. Carcinogenesis 2009 1.23
207 Protective role of miR-155 in breast cancer through RAD51 targeting impairs homologous recombination after irradiation. Proc Natl Acad Sci U S A 2014 1.22
208 MicroRNA expression profiling of male breast cancer. Breast Cancer Res 2009 1.22
209 Fhit interaction with ferredoxin reductase triggers generation of reactive oxygen species and apoptosis of cancer cells. J Biol Chem 2008 1.22
210 Role of microRNAs in lymphoid biology and disease. Curr Opin Hematol 2011 1.22
211 Physical association with WWOX suppresses c-Jun transcriptional activity. Cancer Res 2006 1.21
212 Chronic lymphocytic leukemia: interplay between noncoding RNAs and protein-coding genes. Blood 2009 1.21
213 Fhit tumor suppressor: guardian of the preneoplastic genome. Future Oncol 2008 1.21
214 Negative regulation of BRCA1 gene expression by HMGA1 proteins accounts for the reduced BRCA1 protein levels in sporadic breast carcinoma. Mol Cell Biol 2003 1.20
215 Animal models for chronic lymphocytic leukemia. J Cell Biochem 2007 1.19
216 The Nedd4-binding partner 1 (N4BP1) protein is an inhibitor of the E3 ligase Itch. Proc Natl Acad Sci U S A 2007 1.19
217 FHIT: from gene discovery to cancer treatment and prevention. Lancet Oncol 2002 1.19
218 Targeted ablation of the WW domain-containing oxidoreductase tumor suppressor leads to impaired steroidogenesis. Endocrinology 2008 1.19
219 Inactivation of the Wwox gene accelerates forestomach tumor progression in vivo. Cancer Res 2007 1.19
220 Non-coding RNAs in cancer initiation and progression and as novel biomarkers. Mol Oncol 2011 1.18
221 MicroRNAs/TP53 feedback circuitry in glioblastoma multiforme. Proc Natl Acad Sci U S A 2012 1.18
222 Adenoviral transduction of TESTIN gene into breast and uterine cancer cell lines promotes apoptosis and tumor reduction in vivo. Clin Cancer Res 2005 1.18
223 MicroRNAs: fundamental facts and involvement in human diseases. Birth Defects Res C Embryo Today 2006 1.17
224 MicroRNA expression profiling in human Barrett's carcinogenesis. Int J Cancer 2011 1.17
225 MicroRNA-31 predicts the presence of lymph node metastases and survival in patients with lung adenocarcinoma. Clin Cancer Res 2013 1.17
226 Dysregulation of miR-31 and miR-21 induced by zinc deficiency promotes esophageal cancer. Carcinogenesis 2012 1.16
227 Functional implications of microRNAs in acute myeloid leukemia by integrating microRNA and messenger RNA expression profiling. Cancer 2011 1.16
228 MicroRNA profiling for the identification of cancers with unknown primary tissue-of-origin. J Pathol 2011 1.15
229 Designed FHIT alleles establish that Fhit-induced apoptosis in cancer cells is limited by substrate binding. Proc Natl Acad Sci U S A 2003 1.14
230 Chemoprevention of cigarette smoke-induced alterations of MicroRNA expression in rat lungs. Cancer Prev Res (Phila) 2010 1.13
231 Fez1/Lzts1 absence impairs Cdk1/Cdc25C interaction during mitosis and predisposes mice to cancer development. Cancer Cell 2007 1.13
232 In vivo NCL targeting affects breast cancer aggressiveness through miRNA regulation. J Exp Med 2013 1.13
233 FHIT as tumor suppressor: mechanisms and therapeutic opportunities. Cancer Biol Ther 2002 1.11
234 MicroRNAs in the ontogeny of leukemias and lymphomas. Leuk Lymphoma 2009 1.11
235 The novel deacetylase inhibitor AR-42 demonstrates pre-clinical activity in B-cell malignancies in vitro and in vivo. PLoS One 2010 1.11
236 MicroRNAs as therapeutic targets in chemoresistance. Drug Resist Updat 2013 1.11
237 Regulation of BRCA1 transcription by specific single-stranded DNA binding factors. Mol Cell Biol 2003 1.10
238 Fhit is a physiological target of the protein kinase Src. Proc Natl Acad Sci U S A 2004 1.10
239 Fragile site orthologs FHIT/FRA3B and Fhit/Fra14A2: evolutionarily conserved but highly recombinogenic. Proc Natl Acad Sci U S A 2003 1.09
240 Micro-RNAs in gastrointestinal and liver disease. Gastroenterology 2008 1.09
241 Mutated beta-catenin evades a microRNA-dependent regulatory loop. Proc Natl Acad Sci U S A 2011 1.08
242 The Role of microRNAs in the Tumorigenesis of Ovarian Cancer. Front Oncol 2013 1.08
243 Oncosuppressive role of p53-induced miR-205 in triple negative breast cancer. Mol Oncol 2012 1.07
244 Contact inhibition modulates intracellular levels of miR-223 in a p27kip1-dependent manner. Oncotarget 2014 1.07
245 WW-domain-containing oxidoreductase is associated with low plasma HDL-C levels. Am J Hum Genet 2008 1.06
246 microRNA involvement in hepatocellular carcinoma. Anticancer Agents Med Chem 2011 1.06
247 B-cell malignancies in microRNA Eμ-miR-17~92 transgenic mice. Proc Natl Acad Sci U S A 2013 1.06
248 Characterization of a new chronic lymphocytic leukemia cell line for mechanistic in vitro and in vivo studies relevant to disease. PLoS One 2013 1.06
249 Regression of upper gastric cancer in mice by FHIT gene delivery. FASEB J 2003 1.06
250 MicroRNA-375 and MicroRNA-221: Potential Noncoding RNAs Associated with Antiproliferative Activity of Benzyl Isothiocyanate in Pancreatic Cancer. Genes Cancer 2011 1.06
251 ROR1 can interact with TCL1 and enhance leukemogenesis in Eμ-TCL1 transgenic mice. Proc Natl Acad Sci U S A 2013 1.05
252 miR-155 targets histone deacetylase 4 (HDAC4) and impairs transcriptional activity of B-cell lymphoma 6 (BCL6) in the Eμ-miR-155 transgenic mouse model. Proc Natl Acad Sci U S A 2012 1.05
253 IRF4 mutations in chronic lymphocytic leukemia. Blood 2011 1.05
254 Collecting duct carcinoma of the kidney: an immunohistochemical study of 11 cases. BMC Urol 2004 1.05
255 Reduced FEZ1/LZTS1 expression and outcome prediction in lung cancer. Cancer Res 2005 1.04
256 Tcl1 protein functions as an inhibitor of de novo DNA methylation in B-cell chronic lymphocytic leukemia (CLL). Proc Natl Acad Sci U S A 2012 1.04
257 Intramitochondrial calcium regulation by the FHIT gene product sensitizes to apoptosis. Proc Natl Acad Sci U S A 2009 1.04
258 Knockout mice reveal a tumor suppressor function for Testin. Proc Natl Acad Sci U S A 2005 1.04
259 FEZ1/LZTS1 is down-regulated in high-grade bladder cancer, and its restoration suppresses tumorigenicity in transitional cell carcinoma cells. Am J Pathol 2002 1.03
260 Fragile gene product, Fhit, in oxidative and replicative stress responses. Cancer Sci 2009 1.03
261 miR-29 acts as a decoy in sarcomas to protect the tumor suppressor A20 mRNA from degradation by HuR. Sci Signal 2013 1.02
262 Loss of Hmga1 gene function affects embryonic stem cell lympho-hematopoietic differentiation. FASEB J 2003 1.02
263 Biological functions of mammalian Nit1, the counterpart of the invertebrate NitFhit Rosetta stone protein, a possible tumor suppressor. J Biol Chem 2006 1.02
264 Selected microRNAs define cell fate determination of murine central memory CD8 T cells. PLoS One 2010 1.02
265 Zinc replenishment reverses overexpression of the proinflammatory mediator S100A8 and esophageal preneoplasia in the rat. Gastroenterology 2008 1.02
266 Transcription signatures encoded by ultraconserved genomic regions in human prostate cancer. Mol Cancer 2013 1.01
267 Overexpression of TCL1 activates the endoplasmic reticulum stress response: a novel mechanism of leukemic progression in mice. Blood 2012 1.00
268 Identification of a risk dependent microRNA expression signature in myelodysplastic syndromes. Br J Haematol 2011 1.00
269 Correlation of fragile histidine triad (Fhit) protein structural features with effector interactions and biological functions. J Biol Chem 2008 1.00
270 Restoration of receptor-type protein tyrosine phosphatase eta function inhibits human pancreatic carcinoma cell growth in vitro and in vivo. Carcinogenesis 2004 1.00
271 Down-regulation of homeobox genes MEIS1 and HOXA in MLL-rearranged acute leukemia impairs engraftment and reduces proliferation. Proc Natl Acad Sci U S A 2011 1.00
272 p53 deficiency accelerates induction and progression of esophageal and forestomach tumors in zinc-deficient mice. Cancer Res 2003 0.99
273 MicroRNA regulation of tumorigenesis, cancer progression and interpatient heterogeneity: towards clinical use. Genome Biol 2014 0.99
274 Allelic loss on chromosome 3p21.3 and promoter hypermethylation of semaphorin 3B in non-small cell lung cancer. Cancer Res 2003 0.99
275 Genetic ablation of Ptprj, a mouse cancer susceptibility gene, results in normal growth and development and does not predispose to spontaneous tumorigenesis. DNA Cell Biol 2006 0.99
276 Restoration of fragile histidine triad (FHIT) expression induces apoptosis and suppresses tumorigenicity in breast cancer cell lines. Cancer Res 2003 0.98
277 Overexpression of miR-155 causes expansion, arrest in terminal differentiation and functional activation of mouse natural killer cells. Blood 2013 0.98
278 Suppression of microRNA-9 by mutant EGFR signaling upregulates FOXP1 to enhance glioblastoma tumorigenicity. Cancer Res 2014 0.98
279 MicroRNA in cancer: new hopes for antineoplastic chemotherapy. Ups J Med Sci 2012 0.98
280 ALL1 fusion proteins induce deregulation of EphA7 and ERK phosphorylation in human acute leukemias. Proc Natl Acad Sci U S A 2007 0.97
281 Autoantigen can promote progression to a more aggressive TCL1 leukemia by selecting variants with enhanced B-cell receptor signaling. Proc Natl Acad Sci U S A 2013 0.97
282 Tcl1 interacts with Atm and enhances NF-κB activation in hematologic malignancies. Blood 2011 0.96
283 Inflammation regulates microRNA expression in cooperation with p53 and nitric oxide. Int J Cancer 2011 0.96
284 A new role for microRNAs, as ligands of Toll-like receptors. RNA Biol 2013 0.96
285 The BCSC-1 locus at chromosome 11q23-q24 is a candidate tumor suppressor gene. Proc Natl Acad Sci U S A 2003 0.95
286 Identification of microRNA activity by Targets' Reverse EXpression. Bioinformatics 2009 0.95
287 MiR-181b: new perspective to evaluate disease progression in chronic lymphocytic leukemia. Oncotarget 2012 0.95
288 Retracted POZ-, AT-hook-, and zinc finger-containing protein (PATZ) interacts with human oncogene B cell lymphoma 6 (BCL6) and is required for its negative autoregulation. J Biol Chem 2012 0.95
289 Pathogenetic and clinical relevance of microRNAs in colorectal cancer. Cancer Genomics Proteomics 2009 0.95
290 A differential microRNA profile distinguishes cholangiocarcinoma from pancreatic adenocarcinoma. Ann Surg Oncol 2013 0.93
291 Lung cancer susceptibility in Fhit-deficient mice is increased by Vhl haploinsufficiency. Cancer Res 2005 0.93
292 Zinc deficiency activates S100A8 inflammation in the absence of COX-2 and promotes murine oral-esophageal tumor progression. Int J Cancer 2010 0.93
293 Retracted Targeted disruption of the murine homeodomain-interacting protein kinase-2 causes growth deficiency in vivo and cell cycle arrest in vitro. DNA Cell Biol 2009 0.93
294 Apoptomirs: small molecules have gained the license to kill. Endocr Relat Cancer 2010 0.93
295 A mouse model of the fragile gene FHIT: From carcinogenesis to gene therapy and cancer prevention. Mutat Res 2005 0.93
296 Therapy of human pancreatic carcinoma based on suppression of HMGA1 protein synthesis in preclinical models. Cancer Gene Ther 2004 0.92
297 Cleavage of the transactivation-inhibitory domain of p63 by caspases enhances apoptosis. Proc Natl Acad Sci U S A 2007 0.92
298 MicroRNAs and lung cancer: from markers to targets. Cell Cycle 2011 0.92
299 Frag1, a homolog of alternative replication factor C subunits, links replication stress surveillance with apoptosis. Proc Natl Acad Sci U S A 2005 0.92
300 Hypoxia induces the overexpression of microRNA-21 in pancreatic cancer cells. J Surg Res 2013 0.92
301 Toll-like receptor 3 (TLR3) activation induces microRNA-dependent reexpression of functional RARβ and tumor regression. Proc Natl Acad Sci U S A 2013 0.92
302 Mechanism of human Hb switching: a possible role of the kit receptor/miR 221-222 complex. Haematologica 2010 0.91
303 MicroRNAs in the pathogeny of chronic lymphocytic leukaemia. Br J Haematol 2007 0.91
304 Modulation of gene expression in precancerous rat esophagus by dietary zinc deficit and replenishment. Cancer Res 2005 0.91
305 MicroRNA expression profiling in acute myeloid and chronic lymphocytic leukaemias. Best Pract Res Clin Haematol 2009 0.91
306 GAM/ZFp/ZNF512B is central to a gene sensor circuitry involving cell-cycle regulators, TGF{beta} effectors, Drosha and microRNAs with opposite oncogenic potentials. Nucleic Acids Res 2010 0.91
307 BRCA1 5083del19 mutant allele selectively up-regulates periostin expression in vitro and in vivo. Clin Cancer Res 2008 0.91
308 Zinc supplementation suppresses 4-nitroquinoline 1-oxide-induced rat oral carcinogenesis. Carcinogenesis 2011 0.91
309 Akt regulates drug-induced cell death through Bcl-w downregulation. PLoS One 2008 0.91
310 Fez1/Lzts1-deficient mice are more susceptible to N-butyl-N-(4-hydroxybutil) nitrosamine (BBN) carcinogenesis. Carcinogenesis 2008 0.90
311 MicroRNAs in mouse models of lymphoid malignancies. J Nucleic Acids Investig 2010 0.90
312 Micro-RNA Expression and Function in Lymphomas. Adv Hematol 2011 0.90
313 MicroRNAs in diagnosis and prognosis in cancer: what does the future hold? Pharmacogenomics 2010 0.89
314 Fhit modulates the DNA damage checkpoint response. Cancer Res 2006 0.89
315 Promoter hypermethylation of RASSF1A in esophageal squamous cell carcinoma. Clin Cancer Res 2003 0.89
316 MicroRNA dysregulation in cancer: opportunities for the development of microRNA-based drugs. IDrugs 2010 0.89
317 miR-EdiTar: a database of predicted A-to-I edited miRNA target sites. Bioinformatics 2012 0.89
318 MicroRNAs in cancer: personalizing diagnosis and therapy. Ann N Y Acad Sci 2010 0.88
319 Genome wide identification of recessive cancer genes by combinatorial mutation analysis. PLoS One 2008 0.88
320 Tal1 transgenic expression reveals absence of B lymphocytes. Cancer Res 2006 0.88
321 TNF-alpha signal transduction in rat neonatal cardiac myocytes: definition of pathways generating from the TNF-alpha receptor. FASEB J 2002 0.88
322 Isolation and characterization of a novel gene, hRFI, preferentially expressed in esophageal cancer. Oncogene 2002 0.88
323 HMGA1 protein expression sensitizes cells to cisplatin-induced cell death. Oncogene 2005 0.87
324 Tumor suppressor functions of ARLTS1 in lung cancers. Cancer Res 2007 0.87
325 Synthetic microRNA cassette dosing: pharmacokinetics, tissue distribution and bioactivity. Mol Pharm 2012 0.87
326 The High Mobility Group A2 gene is amplified and overexpressed in human prolactinomas. Cancer Res 2002 0.87
327 Phosphorylation of the human Fhit tumor suppressor on tyrosine 114 in Escherichia coli and unexpected steady state kinetics of the phosphorylated forms. Biochemistry 2005 0.87
328 Transcription factor-mediated epigenetic regulation of cell growth and phenotype for biological control and cancer. Adv Enzyme Regul 2009 0.87
329 Implications of the miR-10 family in chemotherapy response of NPM1-mutated AML. Blood 2014 0.87
330 DLX genes as targets of ALL-1: DLX 2,3,4 down-regulation in t(4;11) acute lymphoblastic leukemias. J Leukoc Biol 2003 0.86
331 Surface expression of Bcl-2 in chronic lymphocytic leukemia and other B-cell leukemias and lymphomas without a breakpoint t(14;18). Mol Med 2008 0.86
332 miRNAs in precancerous lesions of the gastrointestinal tract. World J Gastroenterol 2011 0.86
333 AP-1 elements and TCL1 protein regulate expression of the gene encoding protein tyrosine phosphatase PTPROt in leukemia. Blood 2011 0.86
334 Influence of FHIT on benzo[a]pyrene-induced tumors and alopecia in mice: chemoprevention by budesonide and N-acetylcysteine. Proc Natl Acad Sci U S A 2006 0.86
335 The self-assembly of anticancer camptothecin-dipeptide nanotubes: a minimalistic and high drug loading approach to increased efficacy. Chemistry 2014 0.85
336 Early loss of Fhit in the respiratory tract of rodents exposed to environmental cigarette smoke. Cancer Res 2006 0.85
337 A Sleeping Beauty screen reveals NF-kB activation in CLL mouse model. Blood 2013 0.85
338 Molecular and cytogenetical alterations induced by environmental cigarette smoke in mice heterozygous for Fhit. Cancer Res 2007 0.84
339 Take your "M" time. Cell Cycle 2007 0.84
340 Fhit delocalizes annexin a4 from plasma membrane to cytosol and sensitizes lung cancer cells to paclitaxel. PLoS One 2013 0.84
341 Novel insights in molecular mechanisms of CLL. Curr Pharm Des 2012 0.83
342 Role of PTPRJ genotype in papillary thyroid carcinoma risk. Endocr Relat Cancer 2010 0.83
343 Discovery of PTPRJ agonist peptides that effectively inhibit in vitro cancer cell proliferation and tube formation. ACS Chem Biol 2013 0.83
344 Isolation and functional characterization of peptide agonists of PTPRJ, a tyrosine phosphatase receptor endowed with tumor suppressor activity. ACS Chem Biol 2012 0.83
345 A novel ultrasensitive hybridization-based ELISA method for 2-methoxyphosphorothiolate microRNAs and its in vitro and in vivo application. AAPS J 2010 0.83
346 Tcl1 as a model for lymphomagenesis. Hematol Oncol Clin North Am 2004 0.83
347 MicroRNA in chronic lymphocytic leukemia: transitioning from laboratory-based investigation to clinical application. Cancer Genet Cytogenet 2010 0.82
348 MicroRNA Expression Profiling in the Histological Subtypes of Barrett's Metaplasia. Clin Transl Gastroenterol 2013 0.82
349 Cancer prevention and therapy in a preclinical mouse model: impact of FHIT viruses. Curr Gene Ther 2004 0.81
350 Coordinate loss of fragile gene expression in pancreatobiliary cancers: correlations among markers and clinical features. Ann Surg Oncol 2009 0.81
351 Fez1/Lzts1 a new mitotic regulator implicated in cancer development. Cell Div 2007 0.81
352 MicroRNAs and cancer: introduction. Semin Oncol 2011 0.81
353 MicroRNA dysregulation in acute myeloid leukemia. J Clin Oncol 2013 0.81
354 Akt phosphorylates Tal1 oncoprotein and inhibits its repressor activity. Cancer Res 2005 0.81
355 Effect of zinc supplementation on N-nitrosomethylbenzylamine-induced forestomach tumor development and progression in tumor suppressor-deficient mouse strains. Carcinogenesis 2010 0.81
356 Correction: MiR-34a/c-Dependent PDGFR-α/β Downregulation Inhibits Tumorigenesis and Enhances TRAIL-Induced Apoptosis in Lung Cancer. PLoS One 2015 0.80
357 Preclinical assessment of FHIT gene replacement therapy in human leukemia using a chimeric adenovirus, Ad5/F35. Clin Cancer Res 2006 0.80
358 MicroRNA profiling in ovarian cancer. Methods Mol Biol 2013 0.80
359 Inactivation of the FHIT gene favors bladder cancer development. Clin Cancer Res 2004 0.80
360 LZTS1 downregulation confers paclitaxel resistance and is associated with worse prognosis in breast cancer. Oncotarget 2014 0.80
361 "ApoptomiRs" in vascular cells: their role in physiological and pathological angiogenesis. Vascul Pharmacol 2011 0.80
362 Differentially expressed genes execute zinc-induced apoptosis in precancerous esophageal epithelium of zinc-deficient rats. Oncogene 2004 0.80
363 miR deregulation in CLL. Adv Exp Med Biol 2013 0.79
364 NCCN task force report: molecular markers in leukemias and lymphomas. J Natl Compr Canc Netw 2009 0.79
365 MicroRNA-29b mediates altered innate immune development in acute leukemia. J Clin Invest 2016 0.78
366 Retracted Expression of a truncated Hmga1b gene induces gigantism, lipomatosis and B-cell lymphomas in mice. Eur J Cancer 2010 0.78
367 microRNA-mediated survivin control of pluripotency. J Cell Physiol 2015 0.78
368 Prevention of urinary bladder cancer in the FHIT knock-out mouse with Rofecoxib, a Cox-2 inhibitor. Urol Oncol 2009 0.78
369 Extracellular circulating viral microRNAs: current knowledge and perspectives. Front Genet 2013 0.78
370 Pleiotropic antitumor effects of the pan-HDAC inhibitor ITF2357 against c-Myc-overexpressing human B-cell non-Hodgkin lymphomas. Int J Cancer 2014 0.78
371 Compatible solutes from hyperthermophiles improve the quality of DNA microarrays. BMC Biotechnol 2007 0.78
372 Targeting mature T cell leukemia: new understanding of molecular pathways. Am J Pharmacogenomics 2003 0.78
373 Functional assays for specific targeting and delivery of RNA nanoparticles to brain tumor. Methods Mol Biol 2015 0.77
374 LINCing chromatin remodeling to metastasis. Nat Biotechnol 2010 0.77
375 MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review. EMBO Mol Med 2017 0.76
376 The long journey of TCL1 transgenic mice: lessons learned in the last 15 years. Gene Expr 2015 0.76
377 Purification and biochemical properties of the Drosophila TAC1 complex. Methods Enzymol 2004 0.76
378 Heat shock protein 70 regulates Tcl1 expression in leukemia and lymphomas. Blood 2012 0.76
379 Downregulation of p53-inducible microRNAs 192, 194, and 215 Impairs the p53/MDM2 Autoregulatory Loop in Multiple Myeloma Development. Cancer Cell 2016 0.76
380 Chronic lymphocytic leukaemia. Nat Rev Dis Prim 2017 0.76
381 Self-assembly of a 5-fluorouracil-dipeptide hydrogel. Chem Commun (Camb) 2016 0.76
382 Hmga1 null mice are less susceptible to chemically induced skin carcinogenesis. Eur J Cancer 2007 0.75
383 Correction: In vivo NCL targeting affects breast cancer aggressiveness through miRNA regulation. J Exp Med 2017 0.75
384 Retraction: Are circRNAs involved in cancer pathogenesis? Nat Rev Clin Oncol 2016 0.75
385 Preface. Adv Cancer Res 2017 0.75
386 Genetic and Epigenetic Silencing of MicroRNA-203 Enhances ABL1 and BCR-ABL1 Oncogene Expression. Cancer Cell 2016 0.75
387 POZ-, AT-hook-, and zinc finger-containing protein (PATZ) interacts with the human oncogene B cell lymphoma 6 (BCL6) and is required for its negative autoregulation. J Biol Chem 2017 0.75
388 Fhit interaction with ferredoxin reductase triggers generation of reactive oxygen species and apoptosis of cancer cells. J Biol Chem 2017 0.75
389 A unique microRNA profile in end-stage heart failure indicates alterations in specific cardiovascular signaling networks. J Biol Chem 2016 0.75
390 BRCA1 IVS2-2delA: a deleterious mutation in a family of Asian descent. Cancer Genet Cytogenet 2004 0.75
391 Foreword. Adv Exp Med Biol 2015 0.75